{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:12:50Z","timestamp":1782537170235,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160443"],"award-info":[{"award-number":["82160443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the Guangxi Natural Science Foundation","award":["NO.2020GXNSFAA159023"],"award-info":[{"award-number":["NO.2020GXNSFAA159023"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the independent research project of the Regional Key Laboratory of Early Prevention and Treatment of High-incidence Tumors in 2021","award":["No. GKE-ZZ 202147"],"award-info":[{"award-number":["No. GKE-ZZ 202147"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"the 18th batch of Guangxi \"New Century Ten Hundred Thousand Talents Project\" second-level candidate special fund","award":["NO.2015226"],"award-info":[{"award-number":["NO.2015226"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]},{"name":"Guangxi medical high-level backbone talent training \"139\" plan special fund","award":["NO.G201903032"],"award-info":[{"award-number":["NO.G201903032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01491-2","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T12:03:45Z","timestamp":1730549025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The causal relationship between anti-CD20 antibodies and endometrial cancer: a Mendelian randomization study"],"prefix":"10.1007","volume":"15","author":[{"given":"Jinqiu","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nairong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"key":"1491_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3760\/cma.j.cn112152-20220922-00647","volume":"45","author":"RS Zheng","year":"2016","unstructured":"Zheng RS, Zhang SW, Sun KX, et al. Cancer statistics in China. Zhonghua Zhong Liu Za Zhi. 2016;45:212\u201320. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20220922-00647.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"1491_CR2","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1200\/jco.2017.72.5952","volume":"35","author":"PA Ott","year":"2017","unstructured":"Ott PA, Bang YJ, Berton-Rigaud D, et al. Safety and antitumor activity of pembrolizumab in advanced programmed death ligand 1-positive endometrial cancer: results from the KEYNOTE-028 study. J Clin Oncol. 2017;35:2535\u201341. https:\/\/doi.org\/10.1200\/jco.2017.72.5952.","journal-title":"J Clin Oncol"},{"key":"1491_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00404-023-07149-8","volume":"309","author":"A Giannini","year":"2023","unstructured":"Giannini A, D\u2019Oria O, Corrado G, et al. The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023;309:789\u201399. https:\/\/doi.org\/10.1007\/s00404-023-07149-8.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"1491_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cancers14010034","volume":"14","author":"E Vizza","year":"2021","unstructured":"Vizza E, Bruno V, Cutillo G, et al. Prognostic role of the removed vaginal cuff and its correlation with L1CAM in low-risk endometrial adenocarcinoma. Cancers (Basel). 2021;14(1):34. https:\/\/doi.org\/10.3390\/cancers14010034.","journal-title":"Cancers (Basel)"},{"key":"1491_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/cas.12929","volume":"107","author":"K Ohnishi","year":"2016","unstructured":"Ohnishi K, Yamaguchi M, Erdenebaatar C, et al. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma. Cancer Sci. 2016;107:846\u201352. https:\/\/doi.org\/10.1111\/cas.12929.","journal-title":"Cancer Sci"},{"key":"1491_CR6","doi-asserted-by":"publisher","first-page":"152078","DOI":"10.1016\/j.imbio.2021.152078","volume":"226","author":"A Giatromanolaki","year":"2021","unstructured":"Giatromanolaki A, Kouroupi M, Kontomanolis EN, et al. Regulatory tumor-infiltrating lymphocytes prevail in endometrial tumors with low vascular survival ability. Immunobiology. 2021;226:152078. https:\/\/doi.org\/10.1016\/j.imbio.2021.152078.","journal-title":"Immunobiology"},{"key":"1491_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.4942","volume":"243","author":"A Capobianco","year":"2017","unstructured":"Capobianco A, Cottone L, Monno A, et al. The peritoneum: healing, immunity, and diseases. J Pathol. 2017;243:137\u201347. https:\/\/doi.org\/10.1002\/path.4942.","journal-title":"J Pathol"},{"key":"1491_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/pgp.0000000000000608","volume":"39","author":"LA Friedman","year":"2020","unstructured":"Friedman LA, Ring KL, Mills AM. LAG-3 and GAL-3 in endometrial carcinoma: emerging candidates for immunotherapy. Int J Gynecol Pathol. 2020;39:203\u201312. https:\/\/doi.org\/10.1097\/pgp.0000000000000608.","journal-title":"Int J Gynecol Pathol"},{"key":"1491_CR9","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89-98. https:\/\/doi.org\/10.1093\/hmg\/ddu328.","journal-title":"Hum Mol Genet"},{"key":"1491_CR10","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036\u201345. https:\/\/doi.org\/10.1038\/s41588-020-0684-4.","journal-title":"Nat Genet"},{"key":"1491_CR11","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26:2333\u201355. https:\/\/doi.org\/10.1177\/0962280215597579.","journal-title":"Stat Methods Med Res"},{"key":"1491_CR12","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.joca.2021.08.003","volume":"29","author":"XH Yu","year":"2021","unstructured":"Yu XH, Yang YQ, Cao RR, et al. The causal role of gut microbiota in development of osteoarthritis. Osteoarthritis Cartilage. 2021;29:1741\u201350. https:\/\/doi.org\/10.1016\/j.joca.2021.08.003.","journal-title":"Osteoarthritis Cartilage"},{"key":"1491_CR13","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/art.42304","volume":"74","author":"XF Wang","year":"2022","unstructured":"Wang XF, Xu WJ, Wang FF, et al. Telomere length and development of systemic lupus erythematosus: a Mendelian randomization study. Arthritis Rheumatol. 2022;74:1984\u201390. https:\/\/doi.org\/10.1002\/art.42304.","journal-title":"Arthritis Rheumatol"},{"key":"1491_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x.","journal-title":"Eur J Epidemiol"},{"key":"1491_CR15","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408.","journal-title":"Elife"},{"key":"1491_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jcmm.17638","volume":"27","author":"X Wang","year":"2023","unstructured":"Wang X, Fang A, Peng Y, et al. PHF6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T-cell infiltration. J Cell Mol Med. 2023;27:609\u201321. https:\/\/doi.org\/10.1111\/jcmm.17638.","journal-title":"J Cell Mol Med"},{"key":"1491_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ygyno.2016.11.023","volume":"144","author":"S Bellone","year":"2017","unstructured":"Bellone S, Bignotti E, Lonardi S, et al. Polymerase \u03b5 (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro. Gynecol Oncol. 2017;144:146\u201352. https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.023.","journal-title":"Gynecol Oncol"},{"key":"1491_CR18","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3389\/fimmu.2019.01398","volume":"10","author":"L Lin","year":"2019","unstructured":"Lin L, Hu X, Zhang H, et al. Tertiary lymphoid organs in cancer immunology: mechanisms and the new strategy for immunotherapy. Front Immunol. 2019;10:1398. https:\/\/doi.org\/10.3389\/fimmu.2019.01398.","journal-title":"Front Immunol"},{"key":"1491_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fimmu.2016.00244","volume":"7","author":"N Hiraoka","year":"2016","unstructured":"Hiraoka N, Ino Y, Yamazaki-Itoh R. Tertiary lymphoid organs in cancer tissues. Front Immunol. 2016;7:244. https:\/\/doi.org\/10.3389\/fimmu.2016.00244.","journal-title":"Front Immunol"},{"key":"1491_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Lauss M, Sanna A, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577:561\u20135. https:\/\/doi.org\/10.1038\/s41586-019-1914-8.","journal-title":"Nature"},{"key":"1491_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41379-018-0113-8","volume":"32","author":"M Lee","year":"2019","unstructured":"Lee M, Heo SH, Song IH, et al. Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis. Mod Pathol. 2019;32:70\u201380. https:\/\/doi.org\/10.1038\/s41379-018-0113-8.","journal-title":"Mod Pathol"},{"issue":"9","key":"1491_CR22","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.3390\/cancers12092644","volume":"12","author":"J Tang","year":"2020","unstructured":"Tang J, Ramis-Cabrer D, Curull V, et al. B cells and tertiary lymphoid structures influence survival in lung cancer patients with resectable tumors. Cancers (Basel). 2020;12(9):2644. https:\/\/doi.org\/10.3390\/cancers12092644.","journal-title":"Cancers (Basel)"},{"key":"1491_CR23","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41467-022-29040-x","volume":"13","author":"N Horeweg","year":"2022","unstructured":"Horeweg N, Workel HH, Loiero D, et al. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. Nat Commun. 2022;13:1373. https:\/\/doi.org\/10.1038\/s41467-022-29040-x.","journal-title":"Nat Commun"},{"key":"1491_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3892\/ijo.2020.5042","volume":"57","author":"Y Yamakoshi","year":"2020","unstructured":"Yamakoshi Y, Tanaka H, Sakimura C, et al. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer. Int J Oncol. 2020;57:171\u201382. https:\/\/doi.org\/10.3892\/ijo.2020.5042.","journal-title":"Int J Oncol"},{"key":"1491_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3960\/jslrt.56.89","volume":"56","author":"A Tomita","year":"2016","unstructured":"Tomita A. Genetic and epigenetic modulation of CD20 expression in B-cell malignancies: molecular mechanisms and significance to rituximab resistance. J Clin Exp Hematop. 2016;56:89\u201399. https:\/\/doi.org\/10.3960\/jslrt.56.89.","journal-title":"J Clin Exp Hematop"},{"key":"1491_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1126\/science.abb8008","volume":"369","author":"A Kumar","year":"2020","unstructured":"Kumar A, Planchais C, Fronzes R, et al. Binding mechanisms of therapeutic antibodies to human CD20. Science. 2020;369:793\u20139. https:\/\/doi.org\/10.1126\/science.abb8008.","journal-title":"Science"},{"key":"1491_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fonc.2018.00163","volume":"8","author":"TM Pierpont","year":"2018","unstructured":"Pierpont TM, Limper CB, Richards KL. Past, present, and future of rituximab-the world\u2019s first oncology monoclonal antibody therapy. Front Oncol. 2018;8:163. https:\/\/doi.org\/10.3389\/fonc.2018.00163.","journal-title":"Front Oncol"},{"key":"1491_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.18632\/oncotarget.437","volume":"3","author":"M Schlaak","year":"2012","unstructured":"Schlaak M, Schmidt P, Bangard C, et al. Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells. Oncotarget. 2012;3:22\u201330. https:\/\/doi.org\/10.18632\/oncotarget.437.","journal-title":"Oncotarget"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01491-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01491-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01491-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:18:24Z","timestamp":1730823504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01491-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1491"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01491-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,2]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to our exclusive use of deidentified data, institutional review board approval was not required for our analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"613"}}